OBJECTIVES: To evaluate the impact of obesity on the biopsy detection of prostate cancer.
METHODS: We retrospectively reviewed data of 1182 consecutive Korean patients (≥50 years) with serum prostate-specific antigen levels of 3-10 ng/mL who underwent initial extended 12-cores biopsy from September 2009 to March 2013. Patients who took medications that were likely to influence the prostate-specific antigen level were excluded. Receiver operating characteristic curves were plotted for prostate-specific antigen and prostate-specific antigen density predicting cancer status among non-obese and obese men.
RESULTS: A total of 1062 patients (mean age 67.1 years) were enrolled in the analysis. A total of 230 men (21.7%) had a positive biopsy. In the overall study sample, the area under the receiver operator characteristic curve of serum prostate-specific antigen for predicting prostate cancer on biopsy were 0.584 and 0.633 for non-obese and obese men, respectively (P = 0.234). However, the area under the curve for prostate-specific antigen density in predicting cancer status showed a significant difference (non-obese 0.696, obese 0.784; P = 0.017).
CONCLUSIONS: There seems to be a significant difference in the ability of prostate-specific antigen density to predict biopsy results between non-obese and obese men. Obesity positively influenced the overall ability of prostate-specific antigen density to predict prostate cancer.
Written by:
Kim JH, Doo SW, Yang WJ, Lee KW, Lee CH, Song YS, Jeon YS, Kim ME, Kwon SS. Are you the author?
Department of Urology, College of Medicine, Soonchunhyang University, Cheonan, South Korea.
Reference: Int J Urol. 2014 May 13. Epub ahead of print.
doi: 10.1111/iju.12486
PubMed Abstract
PMID: 24825391
UroToday.com Prostate Cancer Section
